MLchartDataset catalogue

Hepzato

Term · Oncology and biomedicine · MLC-T-ONC-003822

A drug that contains the active ingredient melphalan hydrochloride and is used to treat adults with uveal melanoma (a type of eye cancer) that has spread to less than half of the liver and cannot be removed by surgery. Hepzato is given as an infusion directly into an artery that leads to the liver. It may kill cancer cells by damaging their DNA and stopping them from dividing. Hepzato is a type of alkylating agent.

Table 1. Record
IdentifierMLC-T-ONC-003822
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003822",
  "term": "Hepzato",
  "field": "Oncology and biomedicine",
  "definition": "A drug that contains the active ingredient melphalan hydrochloride and is used to treat adults with uveal melanoma (a type of eye cancer) that has spread to less than half of the liver and cannot be removed by surgery. Hepzato is given as an infusion directly into an artery that leads to the liver. It may kill cancer cells by damaging their DNA and stopping them from dividing. Hepzato is a type of alkylating agent.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/hepzato/"
}

Record 8,400 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.